Status:
Enrolling
AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms
Phase
III
Age
≥18
Sponsor
University Hospital, Brest
Enrollment code
1308
Last Updated
Mar 25, 2025
Locations
42 Countries